Carsten Olbrich
Schering AG
Research Laboratories
Müllerstrasse 178
D-13342
Berlin
Name/email consistency: high
- The in vitro stability of air-filled polybutylcyanoacrylate microparticles. Olbrich, C., Hauff, P., Scholle, F., Schmidt, W., Bakowsky, U., Briel, A., Schirner, M. Biomaterials (2006)
- Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption. Olbrich, C., Gessner, A., Schröder, W., Kayser, O., Müller, R.H. J. Control. Release (2004)
- Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production. Olbrich, C., Schöler, N., Tabatt, K., Kayser, O., Müller, R.H. J. Pharm. Pharmacol. (2004)